Surgalign Holdings, Inc. Announces Date Change for Third Quarter 2020 Earnings Release and Conference Call
Surgalign Holdings, Inc. (Nasdaq: SRGA) has announced a delay in its third quarter 2020 earnings release and conference call due to the additional workload from the recent sale of its OEM business, now classified as discontinued operations.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Surgalign Holdings, Inc. (Nasdaq: SRGA) has announced a delay in its third quarter 2020 earnings release and conference call due to the additional workload from the recent sale of its OEM business, now classified as discontinued operations. The earnings report is anticipated to be released during the week of November 9, 2020. A press release will follow with the new date and time for the call. This delay is attributed to completing financial statements.
Positive
- None.
Negative
- Delay in third quarter 2020 earnings release and conference call.
- Additional workload due to sale of the OEM business impacting financial reporting.
Details
News Market Reaction – SRGA
The recorded move for SRGA in the trading session of this news was +0.56%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DEERFIELD, Ill., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery, including through the application of digital technologies to improve patient outcomes, today announced that it is changing its earnings release and conference call date for the third quarter 2020 as a result of a delay completing the financial statements due to the additional workload created by the recently completed sale of the OEM business and its classification as discontinued operations.
The Company anticipates that it will release its third quarter 2020 earnings and host its conference call during the week of November 9, 2020. The Company will issue a press release announcing the new date and time.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company is building off a legacy of high quality and differentiated products, and continues to invest in clinically validated innovation to deliver better surgical outcomes and improve patient’s lives. Surgalign markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. Surgalign, a member of AdvaMed, is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Marquette, MI, and Wurmlingen, Germany. Learn more at www.surgalign.com and connect on LinkedIn and Twitter.
Forward Looking Statement
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management's beliefs and certain assumptions made by our management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company's SEC filings may be obtained by contacting the company or the SEC or by visiting Surgalign's website at www.surgalign.com or the SEC's website at www.sec.gov.
Jonathon Singer
Investor and Media Contact
jsinger@surgalign.com
+1 224 303 4651
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.